View the full transcript and gain access to JoVE Science Education videos
Q1: Why is Caenorhabditis elegans considered a powerful model organism?
C. elegans offers multiple advantages for research: simple genetics, a transparent body enabling direct observation of internal structures, and ease of cultivation. The worm's short 14-day lifespan, high fertility with hermaphrodites producing 300 eggs, and rapid reproductive maturity at 3.5 days allow researchers to conduct large-scale genetic studies efficiently. Additionally, its completely sequenced genome and conserved genes with humans make it invaluable for understanding development and disease.
Q2: What is the physical structure and life cycle of C. elegans?
C. elegans are microscopic roundworms approximately 1 mm long with elongated cylindrical bodies lacking segmentation and appendages. They exist as hermaphrodites and males, with hermaphrodites capable of self-fertilization. Worms develop through four larval stages (L1-L4) over 14 days total lifespan. Development is temperature-dependent, with laboratory cultures maintained at 15°C, 20°C, or 25°C. Their development and reproduction follows an invariant body plan.
Q3: How are C. elegans cultured in the laboratory?
In the laboratory, C. elegans are cultured on agarose-containing Petri dishes seeded with a lawn of E. coli bacteria, mimicking their natural soil environment with consistent moisture and oxygen levels. Worms can be cultured on either solid or liquid medium, and the system is inexpensive and easy to maintain. This straightforward cultivation method enables researchers to obtain large numbers of worms for genetic screens and experimental studies.
Q4: What genetic tools and techniques make C. elegans ideal for research?
C. elegans can be genetically manipulated through chemical treatment and UV radiation exposure to introduce mutations. High-throughput genome-wide screens are easily performed in 96-well plates, allowing simultaneous screening of numerous genes. The C. elegans Genetic Center maintains a large repository of mutants available to researchers. RNA interference technology enables gene silencing via mRNA degradation, and fluorescent reporters like Green Fluorescent Protein allow visualization of gene expression in live worms.
Q5: How has C. elegans contributed to major biological discoveries?
C. elegans research has yielded landmark discoveries: Sydney Brenner established it as a model system and identified visual phenotypes; John Sulston mapped the complete cell lineage showing six founder cells generate all tissues; Robert Horvitz discovered programmed cell death genes critical for development; Andrew Fire and Craig Mello developed RNA interference technology; Martin Chalfie demonstrated Green Fluorescent Protein expression. These contributions earned four Nobel Prizes and revolutionized understanding of development, genetics, and disease.
Q6: What applications does C. elegans have for studying human biology and disease?
C. elegans serves as a model for studying neurobiology, aging, and human diseases. The worm's 302-neuron nervous system, though lacking a brain, demonstrates sophisticated neural function and communication. Researchers use laser ablation and electrophysiology to map neural connectivity. Fluorescent reporters model protein aggregation in neurodegenerative diseases like Parkinson's and Alzheimer's. Genetic screens identify genes preventing neuronal degeneration, while aging studies reveal conserved longevity genes applicable to human lifespan research.
Q7: How does C. elegans transparency benefit developmental and cellular research?
C. elegans' transparent body throughout its entire life cycle allows researchers to directly observe internal anatomy using light microscopy without dissection. Individual cell lineages can be easily traced during development, enabling detailed study of embryonic processes. Transparency also permits visualization of fluorescent reporters like Green Fluorescent Protein in live worms, facilitating real-time monitoring of gene expression and cellular dynamics during normal development and disease states.